An Open Label, Phase II Trial of Pre-operative Neratinib and Endocrine Therapy with Trastuzumab in Triple Positive Breast Cancers

Status: Open to Accrual

Learn more:

• clinicaltrials.gov: #NCT04886531

Study Contact: studies@hoosiercancer.org; (317) 921-2050.